Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sailing: Conbercept in Diabetic Macular Edema
NCT02194634Phase 3Unknown
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- Jul 2014
- Primary completion
- Dec 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of conbercept in diabetic macular edema (DME), sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Status: unknown.
02
Drugs
conbercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02194634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194634.